Environmental Epigenetics on Human Health and Disease
Epigenetics: Key Concepts
Epigenetics defines gene-expression control by mechanisms not altering the DNA sequence itself. This explains why all cells with the same genome can have different phenotypes.
Epigenomic “marks” are chemical modifications added to DNA or histone proteins, recognized by enzymes that add or remove these marks, shaping chromatin structure and gene activity.
DNA methylation: addition of a methyl group to the 5-carbon of cytosines in CpG dinucleotides, producing 5-methylcytosine (5mC). It tends to repress gene expression when located at promoters.
DNA methylation is catalyzed by DNA methyltransferases (DNMTs), which recruit complexes that inhibit transcription or maintain repressive chromatin.
Histone acetylation: acetyl groups on histone tails open chromatin and promote transcription; controlled by histone acetyltransferases (HATs) and histone deacetylases (HDACs).
Histone methylation and other post-translational modifications (ubiquitination, sumoylation, phosphorylation, biotinylation, ADP-ribosylation) can either promote or suppress gene expression.
The pattern of histone marks on tails is called the histone code, guiding effector proteins to regulate cellular processes.
Non-coding RNAs (ncRNAs) are epigenetic regulators; microRNAs (miRNAs) are ~ RNAs that silence genes post-transcriptionally or transcriptionally. Long non-coding RNAs (lncRNAs) (>200 nt) regulate chromatin states, transcription, and post-transcriptional processes and can be cancer-associated.
Crosstalk exists among epigenetic marks: DNA methylation interacts with histone modifications; histone-modifying enzymes coordinate with DNA methylation. This creates an dynamic “epigenetic network.”
Histone variants add another layer: canonical histones H2A, H2B, H3 have variants (e.g., macroH2A1) that affect chromatin structure during aging, regeneration, and fasting. MacroH2A1 has isoforms macroH2A1.1 and macroH2A1.2 and is linked to aging and cellular senescence.
Epigenetic changes accumulate with aging: altered histone variants, nucleosome remodeling, shifted histone modification patterns, and DNA methylation changes lead to genomic instability and altered gene expression.
Epigenetic marks are dynamic and can be influenced by environment and life experiences, enabling both disease risk and protective responses.
Environmental Epigenetics: How the Environment Shapes the Epigenome
Environmental epigenetics studies how exposures (behavior, nutrition, pollutants) modify epigenetic marks, thereby affecting health.
Identical twins show epigenetic divergence due to different life experiences, environment, and exposures, despite identical DNA.
Epigenetic modifications can result from lifestyle factors such as nutrition and toxin exposure, influencing disease risk including cancer.
Prenatal exposures can program the fetal epigenome, altering disease risk later in life; early-life nutrition is particularly impactful.
Nutrition, Epigenetics, and Health: The Dutch Famine and Beyond
Prenatal nutrition has lasting epigenetic effects that influence postnatal health and disease susceptibility.
Dutch Famine Birth Cohort (1944–1945) shows that extreme prenatal starvation is associated with:
Increased risks of type II diabetes, cardiovascular disease, metabolic disorders, and reduced cognitive function later in life.
Greatest impact when undernutrition occurred in the first months of pregnancy.
Persistent epigenetic differences associated with prenatal famine include changes in DNA methylation of genes involved in insulin metabolism; these differences can persist into adulthood.
Evidence for transgenerational effects of poor maternal diet on metabolic outcomes exists; grandchildren can show health complications, suggesting methylation changes transmitted via germline (maternal or paternal).
Potential molecular mechanisms of transgenerational inheritance include DNA methylation changes in gametes (paternal and maternal lines).
Historical paternal-line examples:
Grandchildren (F2) of a paternal grandmother exposed to famine in her growth period had higher cardiovascular mortality.
Adult grandchildren whose fathers were exposed to famine in utero had higher BMI.
Fetal origins of adult disease may involve mitochondrial dysfunction and oxidative stress early in life after nutrient restriction.
Early-life nutrition can induce long-term DNA methylation changes affecting health and aging.
Mechanisms by which nutrients influence the epigenome include:
Direct enzyme inhibition or activation of DNMTs, HDACs, HATs.
Altering substrate availability for epigenetic enzymes, thereby changing gene expression and health/longevity.
Folate and other methyl-donor nutrients link to DNA methylation via one-carbon metabolism, supporting S-adenosylmethionine (SAM) synthesis, which donates methyl groups for DNA methylation.
Examples of nutrient-epigenome interactions:
Folate metabolism provides methyl groups for SAM synthesis; DNA methylation status can influence expression of cancer-related genes (e.g., p16).
Maternal methyl-donor nutrient availability in early pregnancy is critical for fetal development and long-term cancer risk in offspring.
Dietary methyl-donor deficiency can cause global hypomethylation and lasting phenotypic changes in offspring; supplementation can sometimes reverse such changes.
Calorie restriction can delay aging and has anti-inflammatory effects via pathways including NF-κB and possibly SIRT1; SIRT1 is an NAD+-dependent HDAC linked to epigenetic changes that influence aging.
In animals, maternal diets low in methyl donors before/after birth can permanently alter methylation patterns; supplementing with methyl donors can counteract some epigenetic effects of environmental toxins like BPA.
Honey bees show a striking nutritional-epigenetic effect: royal jelly media epigenetic changes that silence a gene governing queen development, leading to caste differentiation via DNA methylation changes.
Early-life nutrition can influence longevity through long-lasting epigenetic changes; queen bees live up to ~20x longer than workers, illustrating profound “cellular memory.”
Nutritional Epigenetics and Cancer
Folate and vitamin B12 are key methyl donors that influence DNA methylation and cancer risk via methylation of tumor suppressor genes (e.g., p16).
In animal models, dietary folate correlates with higher expression of p16 in aged colons, consistent with DNMT activity changes with aging.
Folate deficiency reduces DNA methylation and can increase risk for colorectal and pancreatic cancers; conversely, folate-rich diets may protect via epigenetic mechanisms.
A broad body of epidemiological evidence links folate and other methyl donors to epigenetic regulation of cancer risk.
Diets rich in fruits/vegetables containing antioxidants can protect against cancer via epigenetic pathways.
Polyphenols (green tea) can inhibit DNA methylation; some dietary factors modulate HDAC/HAT activity.
Epigenetic drugs (HDAC inhibitors) are being explored to treat cancers by restoring differentiation and sensitivity to conventional therapies.
miRNAs interact with epigenetic machinery: miRNAs can regulate DNA methylation and histone modifications; promoter methylation and histone acetylation can also regulate miRNA expression, forming feedback/feed-forward loops. Dysregulated miRNA expression is linked to cancer progression; diets rich in certain nutrients can modulate miRNA expression (e.g., miR-222 as a biomarker of nutritional status; curcumin and retinoic acid as protective agents).
Table 1 (dietary components with epigenetic effects) highlights nutrients, foods, and their epigenetic roles. Key entries include:
Methionine — sesame seeds, brazil nuts, fish, peppers, spinach — SAM synthesis.
Folic acid — leafy vegetables, seeds, liver — Methionine synthesis.
Vitamin B12 — meat, liver, shellfish, milk — Methionine synthesis.
Vitamin B6 — meats, whole grains, vegetables, nuts — Methionine synthesis.
SAM-e — dietary supplement; transfers methyl groups from SAM directly to DNA.
Choline — egg yolks, liver, soy, beef, chicken, turkey — Methyl donor to SAM.
Betaine — wheat, spinach, shellfish, sugar beet — Detoxifies SAM byproducts; supports methylation capacity.
Resveratrol — red wine — Removes acetyl groups from histones, impacting chromatin state.
Genistein — soy — Increases DNA methylation; possible cancer-preventive effects; mechanism not fully understood.
Sulforaphane — broccoli — Increases histone acetylation; activates anti-cancer genes.
Butyrate — produced in gut from dietary fiber fermentation — Increases histone acetylation.
Diallyl sulfide (DADS) — garlic — Increases histone acetylation; activates anti-cancer genes.
Beyond individual nutrients, overall dietary patterns influence epigenetics and phenotype in offspring. Western diets (high in saturated fats, red meat, empty carbs) are linked to hypertension, heart disease, diabetes, obesity, and increased cancer risk; Mediterranean diet shows protective effects against cardiovascular disease and cancer, including breast cancer, possibly via epigenetic mechanisms and gut/breast tissue microbiomes.
In Western diets, fatty acid balance and fats (e.g., n-6/n-3 ratio) can influence NAFLD/NASH development and inflammatory status, thereby impacting epigenetic regulation. Reducing the n-6/n-3 ratio via healthier fats can mitigate oxidative stress and inflammation and restore antioxidant balance.
Early-life and parental diet can influence offspring epigenetics and disease risk later in life, including cardiovascular/metabolic diseases and CNS plasticity. EPA and AA (essential fatty acids) are linked to whole-blood DNA methylation patterns; maternal dyslipidemia can cause placental and fetal liver epigenetic changes and metabolic alterations in offspring.
A recent line of evidence suggests parental diet before/during pregnancy can modify offspring epigenetics and disease risk, including brain development and cardiovascular outcomes.
The Mediterranean diet, rich in fruits, vegetables, whole grains, fish/poultry, healthy fats (extra-virgin olive oil, nuts), is associated with lower cardiovascular risk and cancer incidence; maternal adherence during pregnancy can influence offspring behavior and imprinted gene CpG methylation.
Figure 1 (not shown here) summarizes how diet modulates the epigenome to shape individual and transgenerational phenotypes.
Nutritional Epigenetics: The Future
Nutrients and bioactive food components can reversibly alter DNA methylation, histone modifications, and chromatin remodeling, thereby modifying gene expression and health outcomes.
Bioactive components and dietary patterns may counteract negative life behaviors (e.g., smoking, toxin exposure).
The field is nascent; precise effects and phenotypic associations are still being characterized.
Deciphering epigenetic signatures triggered by specific foods could enable personalized nutrition. For example, DNA methylation signatures associated with fruit/juice intake relate to distinct immunoregulatory pathways, underscoring the potential for food-specific epigenetic profiling.
Chemical Environmental Epigenetics: Endocrine Disrupting Chemicals (EDCs)
Environmental pollutants (metals like arsenic; particulate matter; organic compounds; pesticides) can have epigenetic effects and contribute to disease. EDCs interfere with hormone signaling and can reprogram the epigenome, particularly during early development.
Exposure during fetal life can contribute to diseases that manifest later or in subsequent generations, suggesting epigenetic inheritance of EDC-related effects.
Mechanisms include global effects on epigenetic enzymes (DNMTs, HATs, HDACs) and locus-specific effects via nuclear receptors and co-factors that recruit histone modifiers and DNMTs to specific genomic sites. EDCs can also influence ncRNA expression.
Endocrine-Disrupting Chemicals (EDCs) and Cancer
Prenatal exposure to endocrine disruptors has been linked to reproductive tract cancers in offspring (e.g., DES exposure and vaginal clear cell adenocarcinoma; breast cancer risk with prenatal exposure to estrogens and phytoestrogens).
DES exposure in mice caused uterine tumors and genital tract abnormalities; similar patterns observed in humans; gestational estrogen exposure correlates with later cancer risk.
Phytoestrogens (e.g., genistein) and environmental estrogens can alter mammary gland development, increasing susceptibility to mammary carcinogenesis later in life.
Male offspring exposed in utero to estrogens/anti-androgens showed feminization and reproductive abnormalities; transgenerational transmission of epigenetic changes has been reported in animal models (DES, vinclozolin, BPA, etc.).
Dioxins (potent environmental toxins) mimic estrogen and are linked to immunotoxicity, endocrine disruption, and cancer; they are considered highly toxic synthetic compounds.
Exposure to PAHs (polycyclic aromatic hydrocarbons) from grilled meats is associated with various cancers; some PAHs are genotoxic, others affect cancer promotion via epigenetic mechanisms.
In utero exposure to multiple EDCs can lead to long-term epigenetic changes in target tissues and transgenerational phenotypes.
Epidemiological studies link in utero PAH exposure to poor fetal growth, immune function, and neurodevelopmental outcomes.
Overall, EDCs can alter genome-wide methylation patterns or gene-specific methylation and histone modifications, with potential heritability across generations.
Other Toxin Exposures and Epigenetic Effects
Smoking and alcohol primarily affect disease risk via mutations but also induce epigenetic changes.
Prenatal tobacco exposure is linked to epigenetic marks in buccal cells and later health consequences (respiratory diseases, asthma, allergies, and cancer risk).
Alcohol is a risk factor for multiple cancers and can imprint epigenetic marks during embryonic exposure, potentially affecting memory/learning and development.
Breast Cancer as a Specific Example: Epigenetics and EDCs
EDCs can affect mammary gland development and cancer risk; BPA exposure in utero can induce epigenetic changes and alter gene expression in mammary tissue, increasing postnatal carcinogenic susceptibility.
BPA exposure has been associated with increased H3K4me3 at the alpha-lactalbumin promoter and global mRNA changes after puberty, with histological alterations such as intraductal hyperplasia and DCIS.
Other chemicals (e.g., methoxychlor, triclosan) can modulate cyclin D1 and p21, promoting ovarian cancer growth via estrogen receptor pathways.
Prenatal exposure to dioxin delays mammary gland development and increases sensitivity to carcinogens; atrazine exposure yields similar delayed development.
Epidemiological and experimental data show that gestational exposure to estrogens/phytoestrogens and high-fat diets can alter mammary gland structure and epigenomic patterns, affecting cancer susceptibility later in life.
Transgenerational epigenetic inheritance has been observed for BPA, vinclozolin, and related compounds in animal models, illustrating how ancestral exposure can affect descendant cancer risk.
The Potential of Epigenetic Drugs
Epigenetic regulation is complex: histones and DNA methylation are regulated by two opposing enzyme families that add or remove chemical groups, altering chromatin and gene transcription.
HDAC inhibitors (e.g., vorinostat, romidepsin) impair transcriptional repression, reactivate silenced genes, and can induce growth arrest, differentiation, and apoptosis in malignant cells.
Some epigenetic drugs can restore epigenetic control in cancers with HAT mutations and can enable tumors to respond better to immunotherapy. They may also modulate the tumor immune environment (e.g., reducing IL-10, increasing IFN-γ).
The HDAC family comprises 11 Zn-dependent HDACs divided into four classes: I (HDACs 1, 2, 3, 8), IIA (HDACs 4, 5, 7, 9), IIB (HDACs 6, 10), and IV (HDAC 11); activity and localization differ by class.
Challenges remain due to global genomic effects of epigenetic drugs, requiring careful interpretation of their specific molecular actions.
Conclusions and Take-Home Messages
Human health reflects the integration of genetics with environmental factors (nutrition and pollutants) that act through epigenetic mechanisms.
Epigenetic marks respond to environmental inputs and can be protective or harmful, influencing disease risk, including cancer.
Some epigenetic changes induced by environment may be inherited across generations (transgenerational epigenetic inheritance).
Epigenetic mechanisms (DNA methylation, histone modifications, ncRNAs) are interconnected within a broader epigenetic network.
Diet and nutrition, especially during gestation and early life, can program long-term health and disease susceptibility; maternal/fetal nutrition can influence DNA methylation and chromatin states.
Fruit- and vegetable-rich diets, Mediterranean patterns, and foods rich in bioactive compounds can impact the epigenome and may contribute to cancer prevention and aging processes.
Reversible epigenetic modifications offer potential for personalized nutrition and for combining dietary strategies with epigenetic drugs in cancer prevention and therapy.
Public health implications include improving maternal nutrition and reducing environmental toxin exposure to lower multi-generational disease burdens.
Epigenetic research holds promise for implementing personalized nutrition and risk-management strategies, especially during gestation, and for developing epigenetically informed interventions to reduce cancer susceptibility.
Take-Home Nuances and Practical Considerations
Epigenetic marks are dynamic and depend on the exposure window; some developmental periods are especially susceptible to toxin-induced epigenetic changes.
The same nutrient can have different effects depending on timing, background diet, and epigenetic context; the interplay between methyl donors and epigenetic enzymes matters (e.g., DNMTs, HDACs, HATs).
When designing preventative strategies, consider: dose, exposure window, mixtures of chemicals, and the epigenetic state of target tissues.
A holistic view links diet, lifestyle, exposure, and genetics to epigenetic outcomes that influence disease risk and aging, suggesting multi-modal strategies for health promotion.
Key Numbers and Concepts (selected references in context)
miRNA length:
DNA methylation target: cytosine in CpG dinucleotides; canonical marks include 5-methylcytosine (5mC).
5-methylcytosine formation: via DNMT activity.
SAM is the universal methyl donor for methylation reactions (DNA and histones):
DNA methylation is often associated with gene silencing at promoters, while histone acetylation is associated with transcriptional activation.
Folate and other B vitamins participate in one-carbon metabolism, providing the methyl groups required for SAM synthesis; alterations in this pathway can change global and gene-specific methylation.
SIRT1 is an NAD extsuperscript{+}-dependent HDAC linked to aging; dietary components such as resveratrol may activate SIRT1 and influence DNA methylation through chromatin remodeling.
Monographs and cohort studies cited indicate major public health themes: Dutch Famine cohort outcomes, transgenerational effects, and diet–epigenome interactions across life stages.
The table of nutrients (Table 1) includes methionine, folic acid, B12, B6, SAM-e, choline, betaine, resveratrol, genistein, sulforaphane, butyrate, DADS (diallyl sulfide), with epigenetic roles such as methyl-donor supply, methylation, HDAC inhibition, and histone acetylation changes.